Home Data Calendar Blog

IONS

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Common Stock Value 0.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.120.120.120.120.120.120.120.120.120.120.120.12NA0.120.120.120.120.120.120.120.110.100.100.100.100.100.100.100.100.100.10NANANA
Weighted Average Number Of Diluted Shares Outstanding 143.32143.10142.74NA141.95141.79141.60160.34141.14140.96140.77NA139.71139.35139.43153.30143.41140.25141.54149.86143.31128.71125.33126.86124.37123.99124.97123.95123.38120.80120.60NA119.98127.78NANA122.84NA117.59NANA115.26108.54101.88NA100.68100.21100.16NA99.6999.6099.57NA99.2099.0999.01
Weighted Average Number Of Shares Outstanding Basic 143.32143.10142.74NA141.95141.79141.60141.21141.14140.96140.77139.96139.71139.35139.43140.58140.55140.25138.58137.70143.31128.71125.33124.82124.37123.99122.86121.34120.99120.80120.60NA119.98119.74NANA118.22NA117.59NANA115.26108.54101.88NA100.68100.21100.16NA99.6999.6099.57NA99.2099.0999.01
Earnings Per Share Basic -1.03-0.60-0.87-0.37-0.33-0.74-0.461.59-0.58-0.57-0.64-2.44-0.22-0.23-0.351.310.19-0.010.632.32-0.03-0.29-0.010.020.00-0.090.030.210.06-0.47-0.52-0.59-0.300.30NA-0.140.26-0.23-0.10-0.27NANANANANANANANA-0.20-0.27-0.18-0.20-0.14-0.13-0.25-0.10
Earnings Per Share Diluted -1.03-0.60-0.87-0.37-0.33-0.74-0.461.41-0.58-0.57-0.64-2.44-0.22-0.23-0.351.280.18-0.010.622.21-0.03-0.29-0.010.020.00-0.090.030.210.06-0.47-0.52-0.59-0.300.29NA-0.140.25-0.23-0.10-0.27NANANANA-0.03-0.37-0.01-0.24-0.20-0.27-0.18-0.20-0.14-0.13-0.25-0.10

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Revenue From Contract With Customer Excluding Assessed Tax 144.21188.41130.52151.89159.77133.79141.92440.01133.09125.75111.61290.28160.08145.54133.37493.68167.89163.81297.21192.11145.40117.75144.42172.30118.31112.27115.80160.35110.9338.4736.8751.5749.12120.4391.2062.5884.8644.0657.0828.1642.2523.5938.0943.3619.8711.6047.3423.2332.4020.7124.8221.1526.4228.6223.5029.93
Revenues 144.21188.41130.52151.89159.77133.79141.92440.01133.09125.75111.61290.28160.08145.54133.37493.68167.89163.81297.21192.11145.40117.75144.42172.30120.91104.15110.30160.35110.9338.4736.8751.5749.12120.4391.2062.5884.8644.0657.0828.1642.2523.5938.0943.3619.8711.6047.3423.2332.4020.7124.8221.1526.4228.6223.5029.93
Realized Investment Gains Losses -1.730.83-0.530.00-0.17-0.060.010.160.060.860.015.82NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Gain Loss On Investments -1.940.72-0.533.282.35-6.34-6.625.224.010.860.015.820.839.620.25NANA0.00NANANANANANANANANANANANANANANA0.00NA0.000.580.54-0.260.400.300.170.841.061.450.000.000.024.450.020.03-0.320.45-0.01-0.14-1.01
Cost Of Goods And Services Sold 2.192.541.343.691.514.754.172.233.082.962.583.303.093.012.551.010.971.361.041.820.000.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Costs And Expenses 287.47278.61244.67359.91218.92219.31199.42219.40218.94198.72203.58312.94196.62197.29194.49233.03165.37182.64175.68181.33163.97168.03147.72NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Selling General And Administrative Expense 69.9546.1445.5247.9534.4233.8034.1337.6031.0956.4561.20138.8768.4572.0274.9983.2860.0475.1168.2266.0668.7166.2043.6545.7126.7922.3213.6818.0410.199.8210.56NANANANANANANANANANANANANANANANANANANANANANANANANA
Operating Income Loss -143.26-90.19-114.15-208.02-59.15-85.51-57.50220.60-85.85-72.97-91.97-22.66-36.54-51.75-61.13260.652.52-18.83121.5310.78-18.57-50.28-3.30-1.6913.91-1.6713.9941.1616.11-48.93-54.65-62.94-48.1444.65NA-9.3310.08-21.49-6.65-29.67-19.86-25.50-7.931.62-26.12-28.053.70-18.45-18.62-22.32-14.06-16.11-15.86-8.95-18.67-4.88
Interest Expense 4.202.291.611.732.142.132.122.242.342.362.4111.5111.3211.1710.9913.3612.0011.8011.6011.4611.2811.1110.9410.7910.8211.7811.369.939.759.629.499.359.239.13NA9.027.315.004.964.944.884.874.814.794.825.945.225.185.114.773.443.423.403.343.263.24
Interest Paid Net 0.420.440.090.690.660.950.591.250.662.270.592.550.612.490.604.400.704.110.674.160.684.110.644.010.413.500.113.020.88NANANANANANANANANANANANANANANANANANANANANA0.122.27NANA0.132.28
Gains Losses On Extinguishment Of Debt 2.10NANANANANANA0.000.00-8.63NANANANANANANANANANANANANA7.69-7.69NANA-3.980.00NANANANANANANANANANANANANANANA0.00-4.77NANANANANANANANANANA
Allocated Share Based Compensation Expense 25.9626.5626.9525.6923.8424.5026.2422.2630.5430.0237.8695.0445.8448.4440.7935.0124.1341.9345.5134.1034.8833.8828.4522.3321.4721.2620.9115.1617.5919.2620.1017.4115.0013.61NA13.308.498.127.717.073.102.812.642.871.812.032.462.272.252.362.502.732.712.963.13NA
Income Tax Expense Benefit 6.607.8411.388.100.282.261.090.30-1.310.330.13317.782.65-0.44-3.2634.30-14.91-6.9331.05-291.960.450.360.01-7.160.960.220.002.930.00-0.230.230.370.000.79NA-0.79-15.411.400.88-2.28NANANANA-8.40-0.710.000.000.000.000.010.000.090.000.00NA
Income Taxes Paid 0.200.220.295.010.000.000.000.04NANA0.002.3223.480.050.000.009.040.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Profit Loss NANANA-52.43NANANA224.61-82.47-80.88-89.87-341.43-43.09-43.77-58.48203.9618.43-10.0190.88302.74-20.36-56.57-10.81-4.66-4.90-11.213.4725.867.35-56.85-62.92NANANANA-16.7231.05-26.68-12.08-31.28-24.28-24.57-10.13-1.67NANANANANANANANANANANANA
Net Income Loss -147.41-85.29-124.32-52.43-46.99-105.14-65.17224.61-82.47-80.88-89.87-340.27-30.94-31.84-48.23184.4126.16-0.8884.44320.08-4.56-40.36-1.422.74-0.98-11.213.4725.867.35-56.85-62.92-71.43-35.7835.65NA-16.7231.05-26.68-12.08-31.28NANANANANANANANANANA-17.89-19.99NANA-25.15-9.66
Comprehensive Income Net Of Tax -142.53-87.22-115.83-46.77-56.12-110.56-81.08219.38-84.11-82.47-93.00-341.77-34.08-21.05-50.17184.5025.042.4888.85320.57-4.46-39.74-2.861.28-0.71-11.123.3522.007.71-67.59-65.47-67.04-72.146.95NA-9.3553.91-34.50-16.36-23.36-32.22-22.54-0.923.639.00-37.760.00-23.47-19.65-28.43NANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Assets 2933.972971.132885.222533.882421.972456.132519.092611.692414.892497.072248.552389.763095.703078.953090.913233.112894.992877.762835.892667.782247.912247.321299.561322.021252.561090.831084.00912.47843.59811.11875.82956.11988.00976.26NA955.43955.81793.80817.78834.62847.16881.92788.65552.96545.69485.68472.39470.81484.89505.79529.57505.94550.48NANANA
Liabilities 2618.512542.832398.651960.991827.611831.411809.521839.951884.361914.391567.991546.411489.321484.151520.501548.571397.021420.561448.471480.621407.771429.88912.46903.30854.89875.26882.19812.90703.95699.90717.66755.32742.59675.94NA679.58698.03449.03450.92460.51468.77480.47387.57351.87362.92315.40318.08319.94313.46318.96317.36278.24305.94NANANA
Liabilities And Stockholders Equity 2933.972971.132885.222533.882421.972456.132519.092611.692414.892497.072248.552389.763095.703078.953090.913233.112894.992877.762835.892667.782247.912247.321299.561322.021252.561090.831084.00912.47843.59811.11875.82956.11988.00976.26NA955.43955.81793.80817.78834.62847.16881.92788.65552.96545.69485.68472.39470.81484.89505.79529.57505.94550.48NANANA
Stockholders Equity 315.46428.30486.57572.89594.36624.73709.57771.74530.54582.67680.56843.351383.151377.171360.241471.091336.291269.381207.651048.08710.55696.25301.39330.87307.97215.57201.8199.56139.64111.21158.16200.79245.41300.32NA275.85257.78344.77366.86374.10378.39401.45401.08201.09182.77170.28154.31150.87171.43186.82NANA244.54NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Assets Current 2584.652616.752542.622202.692152.132191.152253.122345.052155.742238.421989.422130.712536.982531.192558.052720.602408.092414.222373.952207.892079.222083.271143.281167.981111.11964.36962.37797.93730.33697.97763.91837.00868.26855.45NA835.43836.60681.16705.80722.05735.51763.30669.06431.83423.44361.59350.42347.61360.14377.09410.72437.39483.14NANANA
Cash And Cash Equivalents At Carrying Value 352.06424.79309.03276.47314.99521.92542.51869.19632.95565.12414.15397.66633.06530.18486.19683.29247.94272.52375.81278.82479.89805.49227.50129.63159.18132.99114.2284.6984.28112.5393.34128.80126.59119.49NA148.35143.0073.2294.08161.78159.97256.41296.54107.65124.4884.5685.6456.3965.4855.2685.0286.2070.05100.1246.0498.59
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 352.06424.79309.03276.47314.99521.92542.51869.19632.95565.12414.15397.66633.06530.18486.19683.29247.94272.52375.81278.82479.89805.49227.50129.63NANANA84.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Short Term Investments 1883.521960.602037.751710.401666.671499.91NA1245.78NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Inventory Net 25.6325.5422.2022.0320.6419.8124.0324.8122.9324.1022.2021.9622.1723.7222.8918.1819.3818.5011.068.588.38NANA9.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Inventory Finished Goods 0.180.200.220.160.290.310.470.390.611.561.913.000.950.740.600.26NANANA0.09NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Assets Current 181.07177.87159.72168.25143.17142.76150.58143.37136.64131.04123.83140.16146.63131.01122.47139.84118.81102.0798.69102.4797.1276.9962.0672.3348.9351.5325.9314.7615.2417.2517.4014.7729.0729.87NA13.1515.698.358.579.817.527.375.798.078.737.805.727.425.427.557.617.387.06NANANA
Equity Securities Fv Ni 49.5551.2150.3850.9147.6345.11NA50.53NANANANANANANANA0.610.900.971.35NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Available For Sale Securities Debt Securities 1884.511998.232038.751721.391701.031523.27NA1248.12NANANANANANANANANANANANANANANANANANANANANANANA657.94NANANANA605.91NANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NANANA87.72NANANA102.65NANANA87.38NANANA74.01NANANA61.47NANANA87.68NANANA80.08NANANA72.71NANANANA66.05NANANA60.43NANANA54.47NANANA47.42NANANA40.83NANANA
Amortization Of Intangible Assets 0.660.640.610.610.610.600.590.610.600.590.540.540.530.510.490.770.190.480.470.470.460.450.44NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Property Plant And Equipment Net 70.9391.6385.1674.29180.81177.01177.72178.07180.14179.32180.41181.08181.52172.62163.95153.65148.72135.35133.52132.16132.00127.94123.19121.91116.6299.6895.4492.8490.9790.6090.3690.2389.2489.69NA89.0588.9688.0786.3286.6486.2087.2788.3189.6991.0892.6094.0195.1396.6198.0288.0137.6835.70NANANA
Finite Lived Intangible Assets Net NANANANA29.6129.0529.3029.0030.0429.3728.8027.9428.2727.7026.7525.6726.9826.0625.2224.0324.0323.4522.9122.00NANANA20.36NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Assets Noncurrent 104.0886.0378.3075.3459.4358.9258.9559.5748.9749.9649.9250.0341.1941.4732.5527.6326.2025.7825.9512.9112.6612.6510.1810.132.925.43NA1.32NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Equity Securities Fv Ni 49.5551.2150.3850.9147.6345.11NA50.53NANANANANANANANA0.610.900.971.35NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Available For Sale Debt Securities Amortized Cost Basis 1900.532019.272057.801748.841733.601547.09NA1251.17NANANANANANANANANANANANANANANANANANANANANANANA660.46NANANANA606.89NANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Liabilities Current 404.21287.98259.22311.56283.45267.81228.45240.55279.78293.82295.11583.25244.57231.34258.02273.00231.78241.21252.47280.29260.24248.62212.64224.74177.65191.76170.58133.78106.89111.08124.50148.88122.20102.13NA100.29115.33107.33100.82100.8497.81103.2887.0070.3074.3251.6055.0661.7176.1183.5491.9894.40105.89NANANA
Long Term Debt Current NANANA0.15NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accounts Payable Current 5.6224.0210.5017.9220.5510.3516.1211.908.3614.669.5117.2016.227.4121.1716.0713.1515.6313.3328.6613.5813.2913.8324.8923.5213.2723.2421.1215.6817.5819.4628.3619.2910.95NA16.4917.9815.6313.459.8711.018.789.465.3810.245.266.195.348.306.653.074.656.52NANANA
Other Accrued Liabilities Current 13.6210.899.6012.2013.05NANA12.31NANANA30.86NANANA32.02NANANA13.94NANANA16.48NANANA6.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accrued Income Taxes Current 31.0724.7317.296.250.020.010.900.040.451.881.331.328.9327.9432.9532.511.954.0418.400.86NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accrued Liabilities Current 118.97104.75112.70140.10128.00134.3499.2688.5675.6875.1578.7790.1680.7567.8062.5166.7752.6249.6845.1348.3650.7958.4966.4766.6233.9635.8830.8736.0123.6218.9826.1728.1124.4923.75NA23.7530.4529.1425.1727.9022.0922.2816.5117.7615.4011.9015.6215.6018.6615.0710.878.1312.39NANANA
Other Liabilities Current 9.958.908.247.54NANANA3.53NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Contract With Customer Liability Current 204.8296.2592.3390.5899.5193.3991.4497.7197.92102.07106.74108.38104.43100.40120.81118.27137.61137.39144.85160.26157.15160.59120.13125.34NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Long Term Debt NANANA1194.23NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Long Term Debt Noncurrent NANANA1175.72NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Liabilities Noncurrent 48.8016.447.497.13NANANA6.95NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating Lease Liability Noncurrent 173.04175.02177.00178.94NANANA19.43NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Stockholders Equity 315.46428.30486.57572.89594.36624.73709.57771.74530.54582.67680.56843.351383.151377.171360.241471.091336.291269.381207.651048.08710.55696.25301.39330.87307.97215.57201.8199.56139.64111.21158.16200.79245.41300.32NA275.85257.78344.77366.86374.10378.39401.45401.08201.09182.77170.28154.31150.87171.43186.82NANA244.54NANANA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 315.46428.30486.57572.89594.36624.73709.57771.74530.54582.67680.56843.351606.381594.801570.411684.551497.971457.201387.421187.16840.14817.44387.10418.72397.67NANA99.56NANANA200.79NANANANA257.78NANANA378.39NANANA182.77NANANA171.43NA212.22227.70244.54NANANA
Common Stock Value 0.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.120.120.120.120.120.120.120.120.120.120.120.12NA0.120.120.120.120.120.120.120.110.100.100.100.100.100.100.100.100.100.10NANANA
Additional Paid In Capital Common Stock 2148.002118.312089.362059.852034.552008.791983.081964.171942.351910.381925.802113.652311.682271.632233.642203.782219.092177.222117.972047.252030.312011.561576.951549.901528.191434.991410.101311.231373.311352.591331.941309.111286.691269.45NA1251.931224.511365.411352.991343.871324.801315.641292.741091.841077.151073.661019.941016.501013.591009.331006.291003.601000.18NANANA
Retained Earnings Accumulated Deficit -1786.65-1639.24-1553.95-1429.62-1377.19-1330.20-1225.07-1159.90-1384.52-1302.05-1221.17-1249.37-909.10-878.15-846.31-707.53-857.56-883.73-882.85-967.29-1287.37-1282.81-1242.45-1187.40-1190.14-1189.17-1177.96-1181.43-1207.29-1214.64-1157.79-1094.87-1023.44-987.66NA-1023.31-1006.59-1037.65-1010.97-998.89-967.61-943.33-918.76-908.64-906.97-904.33-866.69-865.48-841.49-821.45-794.57-776.68-756.69NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -46.04-50.91-48.98-57.48-63.14-54.01-48.58-32.67-27.44-25.80-24.20-21.07-19.57-16.44-27.23-25.29-25.38-24.25-27.61-32.02-32.53-32.63-33.23-31.76-30.20-30.37-30.46-30.36-26.50-26.85-16.11-13.56-17.9618.41NA47.1139.7516.8924.7229.0021.0829.0226.9917.7812.480.850.97-0.24-0.77-1.150.400.690.95NANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 25.9626.5626.9525.6923.8424.5026.2422.2630.5430.0237.8695.0445.8448.4440.7935.0124.1341.9345.5134.1034.8833.8828.45NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Net Cash Provided By Used In Operating Activities -109.02-97.36-133.99-200.19-24.43-18.10-31.65203.69-55.57-62.65-54.6697.98-10.36-44.14-7.58277.93-12.81-27.11107.70115.49-26.00500.2413.1620.4028.722.36122.67-26.8424.29NANANANANANANANANANANANANANANANA-24.87-2.58-6.71-24.33-24.45-26.18-39.84-25.50-21.435.03-21.69
Net Cash Provided By Used In Investing Activities 68.7169.52-325.64212.15-183.93-3.30-287.5595.11121.97-101.0378.86187.85101.9479.69-95.01138.191.40-110.69-70.17-326.21-307.67-375.1779.49-54.21-150.1014.70-168.6820.80-57.09NANANANANANANANANANANANANANANANA-10.6124.09-0.5233.96-4.4224.6456.72-7.2475.91-59.9414.96
Net Cash Provided By Used In Financing Activities -32.27143.54492.09-51.021.831.22-7.33-62.491.46314.54-7.58-521.4810.948.44-94.5019.23-13.1734.5159.469.658.08452.925.224.26147.571.7175.556.454.54NANANANANANANANANANANANANANANANA34.407.74-1.850.58-0.890.36-0.732.67-0.402.350.07

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Net Cash Provided By Used In Operating Activities -109.02-97.36-133.99-200.19-24.43-18.10-31.65203.69-55.57-62.65-54.6697.98-10.36-44.14-7.58277.93-12.81-27.11107.70115.49-26.00500.2413.1620.4028.722.36122.67-26.8424.29NANANANANANANANANANANANANANANANA-24.87-2.58-6.71-24.33-24.45-26.18-39.84-25.50-21.435.03-21.69
Net Income Loss -147.41-85.29-124.32-52.43-46.99-105.14-65.17224.61-82.47-80.88-89.87-340.27-30.94-31.84-48.23184.4126.16-0.8884.44320.08-4.56-40.36-1.422.74-0.98-11.213.4725.867.35-56.85-62.92-71.43-35.7835.65NA-16.7231.05-26.68-12.08-31.28NANANANANANANANANANA-17.89-19.99NANA-25.15-9.66
Profit Loss NANANA-52.43NANANA224.61-82.47-80.88-89.87-341.43-43.09-43.77-58.48203.9618.43-10.0190.88302.74-20.36-56.57-10.81-4.66-4.90-11.213.4725.867.35-56.85-62.92NANANANA-16.7231.05-26.68-12.08-31.28-24.28-24.57-10.13-1.67NANANANANANANANANANANANA
Increase Decrease In Inventories 0.103.340.171.390.83-4.22-0.771.88-1.171.900.23-0.21-1.550.842.18-1.200.873.262.480.20-0.690.01-0.921.531.95-0.30-0.69-1.831.651.15-0.380.32-0.20-0.06NA0.55-0.80-0.690.24-0.500.65-0.922.50-0.31NANANANANANANANANANANANA
Increase Decrease In Accounts Payable -17.9815.81-10.29-4.518.28-5.552.884.74-7.926.75-9.578.213.97-15.350.412.42-2.661.09-17.1912.950.63-1.09-13.143.498.32-10.500.474.52-2.76-1.02-11.428.359.06-5.50NA-2.693.41-0.584.64-2.652.36-0.463.74-5.57NANANANANANANANANANANANA
Share Based Compensation 25.9626.5626.9525.6923.8424.5026.2422.2630.5430.0237.8695.0445.8448.4440.7935.0124.1341.9345.5134.1034.8833.8828.4522.3321.4721.2620.9115.1617.5919.2620.1017.4115.0013.61NA13.308.498.127.717.073.102.812.642.87NANANANANANANANANANANANA
Amortization Of Financing Costs 1.701.481.491.341.351.341.341.371.391.330.860.690.650.640.590.490.490.480.470.470.490.410.440.410.410.400.400.320.310.300.300.290.290.28NA0.280.180.140.140.140.110.110.100.10NANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Net Cash Provided By Used In Investing Activities 68.7169.52-325.64212.15-183.93-3.30-287.5595.11121.97-101.0378.86187.85101.9479.69-95.01138.191.40-110.69-70.17-326.21-307.67-375.1779.49-54.21-150.1014.70-168.6820.80-57.09NANANANANANANANANANANANANANANANA-10.6124.09-0.5233.96-4.4224.6456.72-7.2475.91-59.9414.96
Payments To Acquire Property Plant And Equipment 2.1412.0110.474.145.543.332.712.503.324.361.775.1511.799.109.087.7615.904.013.231.393.246.632.348.2617.056.223.242.791.052.630.632.411.343.06NA0.883.550.871.701.400.440.520.370.220.450.170.750.11-0.321.673.412.580.500.850.8911.01

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Net Cash Provided By Used In Financing Activities -32.27143.54492.09-51.021.831.22-7.33-62.491.46314.54-7.58-521.4810.948.44-94.5019.23-13.1734.5159.469.658.08452.925.224.26147.571.7175.556.454.54NANANANANANANANANANANANANANANANA34.407.74-1.850.58-0.890.36-0.732.67-0.402.350.07

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Revenues 144.21188.41130.52151.89159.77133.79141.92440.01133.09125.75111.61290.28160.08145.54133.37493.68167.89163.81297.21192.11145.40117.75144.42172.30120.91104.15110.30160.35110.9338.4736.8751.5749.12120.4391.2062.5884.8644.0657.0828.1642.2523.5938.0943.3619.8711.6047.3423.2332.4020.7124.8221.1526.4228.6223.5029.93
Revenue From Contract With Customer Excluding Assessed Tax 144.21188.41130.52151.89159.77133.79141.92440.01133.09125.75111.61290.28160.08145.54133.37493.68167.89163.81297.21192.11145.40117.75144.42172.30118.31112.27115.80160.35110.9338.4736.8751.5749.12120.4391.2062.5884.8644.0657.0828.1642.2523.5938.0943.3619.8711.6047.3423.2332.4020.7124.8221.1526.4228.6223.5029.93
Collaborative Agreement Revenue 44.1791.0138.3349.9469.2538.2549.78352.7448.2739.8927.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Commercial 84.0877.9067.7780.4872.4178.1872.2887.2784.8285.8684.4595.6695.3489.7383.96100.3695.7088.3068.0972.9582.7657.2042.0253.9134.6223.697.80NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Eplontersen Joint Development Revenue 15.9619.5024.4221.4718.1117.3619.85NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Ion859 NANANANANANA10.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Licensing And Other Royalties 8.546.2311.045.674.848.1712.319.622.732.154.621.572.131.622.795.572.087.931.620.5212.750.550.941.831.731.322.59NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Commercial 16.8316.89NANA10.7618.56NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Research And Development Revenue 60.13110.5162.7671.4187.3655.6169.63352.7448.2739.8927.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Spinraza Royalties 67.2561.0150.2567.2261.6559.6353.8269.0566.5772.1759.9974.6674.1771.7566.0181.1181.6770.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product 8.2910.656.487.585.9210.396.168.6015.5211.5419.8419.4419.0416.3615.1613.6911.959.876.752.240.00NA0.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Tofersen, Subsequent Event, Biogen Collaboration2013 Strategic Neurology NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Bepirovirsen, Glaxo Smith Kline Collaboration NANA15.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Ion839, Astrazeneca Collaboration Cardiovascular Renal And Metabolic Diseases NA20.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Ion859, Biogen Collaboration2013 Strategic Neurology NANANANANANA10.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Research And Development Revenue, Biogen Collaborations NANA20.2539.8027.4017.3040.1097.6017.4027.8018.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Research And Development Revenue, Glaxo Smith Kline Collaboration NANA15.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Research And Development Revenue, Roche Collaborations 8.86NANA1.8041.50NANA5.803.90NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Spinraza Royalties, Biogen Collaborations NANA50.2567.2061.6059.6053.8069.1066.6072.2060.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Tegsedi, Swedish Orphan Biovitrum A B Distribution Agreement 0.79NANANA1.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Subsequent Event, Biogen Collaboration2013 Strategic Neurology NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Subsequent Event, Glaxo Smith Kline Collaboration NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Subsequent Event, Roche Collaboration Ionis Fb L For Complement Mediated Diseases NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Astrazeneca Collaboration Eplontersen NA20.00NANANANANA200.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Astrazeneca Collaborations 15.9659.50NANA18.1117.77NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Biogen Collaboration2013 Strategic Neurology NA16.00NANA9.00NA18.00NANANANANANANANANA-16.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Biogen Collaborations 94.6997.4070.50107.0089.0076.9093.90166.7084.00100.0078.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Biogen Collaborations2013 Strategic Neurology And2012 Neurology NANANANA13.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Glaxo Smith Kline Collaboration 0.00NANANANANANANANANANANANANANANA25.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Novartis Collaborations 1.91NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Roche Collaboration Ionis Fb L For Complement Mediated Diseases NANANANA35.0013.80NANANANANA-9.20NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Roche Collaborations NANANANANA19.50NANANA3.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Net Income Loss
Expenses
Cost Of Goods And Services Sold
Balance Sheet
Finite Lived Intangible Assets Net
Assets
Inventory Net
Current Assets
Inventory Net
NonCurrent Assets
Finite Lived Intangible Assets Net
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Other Liabilities
Current Liabilities
Long Term Debt Current
Noncurrent Liabilities
Other Liabilities Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Next Twelve Months
InventoryNet
Inventory Finished Goods

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
('ions:ResearchAndDevelopmentRevenue', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:TypeOfArrangement
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Type Of Arrangement
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:EquitySecuritiesFvNi
us-gaap:FinancialInstrument
(None,)
Equity Securities Fv Nius-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:FairValueByMeasurementFrequency
(None, 'us-gaap:FairValueMeasurementsRecurring')
Equity Securities Fv Nius-gaap: Schedule Of Equity Method Investment Equity Method Investee Name, us-gaap: Fair Value By Measurement Frequency
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)
Equity Securities Fv Nius-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
(None, 'us-gaap:FairValueMeasurementsRecurring', 'ions:EquitySecuritiesPubliclyTradedCompanies')
Equity Securities Fv Nius-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel3', 'us-gaap:FairValueMeasurementsRecurring', None)
Equity Securities Fv Nius-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', 'us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:CashAndCashEquivalents', 'us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Balance Sheet Location, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:EquitySecuritiesFvNi
us-gaap:FinancialInstrument
(None,)
Equity Securities Fv Nius-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:FairValueByMeasurementFrequency
(None, 'us-gaap:FairValueMeasurementsRecurring')
Equity Securities Fv Nius-gaap: Schedule Of Equity Method Investment Equity Method Investee Name, us-gaap: Fair Value By Measurement Frequency
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)
Equity Securities Fv Nius-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
(None, 'us-gaap:FairValueMeasurementsRecurring', 'ions:EquitySecuritiesPubliclyTradedCompanies')
Equity Securities Fv Nius-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel3', 'us-gaap:FairValueMeasurementsRecurring', None)
Equity Securities Fv Nius-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
('ions:ResearchAndDevelopmentRevenue', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:TypeOfArrangement
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Type Of Arrangement